resin activity (3.0 t 3 .7 vs. 1 .2 t 1 .2 ng/nil per h, p < 0 .001), arginine vasopressin (1 .9 t 6 .9 vs. 0.7 t 0 .3 ply/ml, p < 0.001) and atrial natriuretic peptide (75 ± 75 vs . 21 t 9 pg/ml, p < 0.001) values ranged from normal to very high, indicating a wide spectrum of neurohumoral activation. Activation of one system did not correlate with activation of another . The clinical and laboratory variables rest closely associated with neurohuinorai activation were Killip dam, left ventricular ejection fraction, age and use of diuretic drugs . The association between neurohumoral activn icn and clinical and laboratory variables varied from one neurohormone to another .
Conclusions. Neurohuntoral activation occurs in a significant proportion of patients at the time of hospital discharge after infarction. Which seurohormote is activated and which clinical and laboratory variables determine this activation vary from one neurobormone to another.
(J Am Coil Cardiol 1993; 22 :390-8) heart failure or are receiving diuretic drugs, in whom plasma resin activity is increased, and patients with left ventricular dysfunction, in whom atria) natriuretic peptide levels remain elevated . This relative lack of sustained neurohumoral activation appears to be at odds with data from clinical studies documenting beneficial effects when treatment with beta-adrenergic blocking agents or angiotensinconverting enzyme inhibitors is started at the time of hospital discharge .
Patients with left ventricular dysfunction but no overt heart failure after myocardial infarction are a high risk subgroup in which the use of therapeutic interventions that block the effects of neurohumoral activation are known to prolong survival and decrease cardiovascular morbidity (2, 3) . The relative efficacy of angiotensin-converting enzyme inhibition in the Survival and Ventricular Enlargement study (SAVE) (3) in patients with a left ventricular ejection frac-tion >_3l% and the lack of efficacy in this subgroup in the Study of Left Ventricular Dysfunction (SOLVD) (4, 5) would argue in favour of specific pathophysiologically important consequences of neurohumoral activation during the early postinfarction period . Also, the use of beta-blockers in this subgroup of postinfarction patients has been found to be particularly useful in preventing further morbidity and mortality, whereas the benefits of beta-blockers on survival of patients with chronic heart failure remains unproved (6) . Further studies to document the degree and range of neurohumoral activati: n, previously thought to be generally absent in these patients, as well as the factors driving this activation, are thus relevant and may be useful in identifyin patients in this subgroup at particular risk of subsequent morbidity or mortality .
In this study, 519 patients with left ventricular dysfunction (left ventricular ejection fraction X40%) but without overt heart failure had circulatory neurohumoral levels measured a mean of 12 days after myocardial infarction . The degree of neurohumoral activation was then correlated with the clinical and laboratory characteristics of these patients . Our hypothesis was that widespread neurohumoral activation persists in some patients until at least the time of hospital discharge after infarction and that the determinants of activation vary from one neurohumoral system to another. Our objectives were thus to better understand the extent of and the pathophysiologic mechanisms contributing to activation of a given neurohormone in the early (1 to 2 weeks) postinfarction period .
Methods
Study patients. The 519 patients included in this study were drawn from the Survival and Ventricular Enlargement (SAVE) study. That study is a randomized multicenter trial testing the hypothesis that the angiotensin-converting enzyme inhibitor captopril started 3 to 16 days after infarction improves survival and reduces the incidence of a major deterioration in ejection fraction (?9% units) in survivors of acute myocardial infarction . The method used to estimate left ventricular ejection fraction was equilibrium multigated radionuclide ventriculography performed after the labeling of red blood cells by technetium-99 m. The SAVE radionuelide ventricutography-left ventricular ejection fraction core laboratory reviewed the findings of radionuclide ventriculography in patients randomly selected by the SAVE data coordinating center at baseline, permitting an assessment of radionuclide ventriculography and left ventricular ejection fraction quality and confirming the presence of a low ejection fraction . Only patients with left ventricular dysfunction (defined as a left ventricular ejection fraction s40% at the clinical sites) and no overt heart failure or heart failure responsive to digitalis or diuretic drugs (defined as lack of pulmonary rales on physical examination at the time of randomization despite the use of digoxin or diuretic drugs, or both) were included in the study. Exclusion criteria included contraindications to capto-ROULEAU ET AL .
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pril and concurrent medical problems such as renal insufficiency (creatinine >2 .5 mgldl), severe valvular disease, refractory hypertension, malignancy or other conditions thought to limit survival, geographic problems or inability to give informed consent (3) . Patients with ischemic symptoms or with a markedly positive exercise test were also excluded from the study unless cardiac catheterization and appropriate revascularization procedures were conducted before randomization . All patients gave written informed consent agreeing to have extra blood samples drawn .
Ten Canadian and three American centers participated in this substudy . Patient recruitment began on November 27, 1987 and ended on January 28, 1990 . Patients were recruited a mean of 12 days (median 12) after myocardial infarction . Their average age was 60 ± 11 years and there were 93 women and 426 men . Thirty-four percent had a history of hypertension, 19% a history of diabetes and 35% a history of prior myocardial infarction .
The mean maximal increase in creatine kinase during the infarction was 13 .4 times the upper limit of normal . The Killip class during the acute phase of the myocardial infarction was I in 57%, II in 39%, III in 8% and IV in 1%, where Killip class I = no rates and no third heart sound, Killip class II = rates in 550% of the lung field or third heart sound ; Killip class III = rates in >50% of the lung field (pulmonary edema) ; and Killip class IV = cardiogenic shock (clinically determined) . The mean left ventricular ejection fraction was of 31 ± 7% . Thirty-one percent of patients had received thrombolytic agents and 70 patients (3%) underwent a revascularization procedure (coronary artery bypass surgery in 31 and coronary angioplasty in 39) during the interval between their myocardial infarction and neurohumoral testing . Patients who had a revascularization procedure had clinical, laboratory and neurohumoral values similar to those of other patients and were thus considered together with the rest of the group . At the time of neurohumoral sampling, 35% of patients were receiving diuretic drugs, 33% were receiving beta-blockers, 43% were receiving nitrates, 28% were receiving digoxin, 25% were receiving calcium channel blockers and no patients were receiving angiotensin-converting enzyme inhibitors or other vasodilators .
Thirty-eight age-matched people (57 = 7 years, l` women and 24 men) were used as control subjects . These control subjects had no known disease and were receiving no medication. Control subjects were volunteers wort ;^a -n the various participating centers, and neurohumoral sans_-. ' were obtained and handled in a fashion similar to those of the SAVE patients . Neurohumoral measurements. After an overnight fast, an indwelling venous catheter was inserted and the patient was permitted to rest in the supine position for 30 min . Blood was sampled for plasma norepinephrine, epinephrine, dopamine, renin activity, aldosterone, arginine vasopressin and atrial natriuretic peptide . Blood was also drawn for measurement of serum electrolytes, blood urea nitrogen, creatinine, glucose and osmolality to verify sample quality . Mean arterial pressure (84 ± 11 nm Hg) and heart rate (77 ± 19 beats/min) were also measured . Samples were then frozen at -80°C and sent monthly to the central laboratory (H6pital du SacrdCoeur de Montreal) packed in dry ice . All sample transfers between peripheral and central lanoratories took <24 h . No sample was delayed, hemolyzed or thawed . Neurohormones were measured monthly as soon as received to minimize the inevitable loss of atria) natriuretic peptide during storage (7) . The methods used to treasure neurohumoral levels have been previously described (8) .
Statistical analyses . All statistical analysis was performed using the Statistical Analysis System (SAS) . Participants who took part in the substudy of SAVE had data collected on the standarG SAVE study forms ; control subjects had data collected separately . The SAVE substudy participants had descriptive statistics measures of demographic and clinical information . Participants in the control group had their mean values for neurohormones (with standard deviation) computed . The neurohormones of the SAVE participants in the substudy were compared with those in the control subjects . Unpaired t tests were used to evaluate the statistical significance of the differences in the mean values of the neurohormones in these two groups .
Subsequent analyses to identify relations between neurohormonal levels at the time of entry to SAVE and baseline demographic and clinical variables were restricted to those participants of SAVE involved in the substudy . The univariate analyses consisted of the quantification of the relation between each of the neurohormonal levels and each of the following demographic and clinical information : age, left ventricular ejection fraction, diuretic drug use, Killip class, use of thrombolytic therapy, number of days between the index myocardial infarction and randomization, prior myocardial infarction, peak creatine kinase, gender, diabetes, blood pres- Table 1 . Comparison of Neurohormones in Survival and Ventricular Enlargement (SAVE) Study Patients and Normal Control Subjects sure elevation requiring therapy before the myocardial infarction, systolic blood pressure at the time of neurohumoral sampling and the use of beta-blockers, nitrates, calcium channel blockers or digoxin. The variables involving medication indicated the medication use at the time of neurohumoral sampling. These univariate relations were assessed using simple linear regression procedures. All p values were based on the value of the coefficients from the regression analysis and any p value < 0 .05 was considered statistically significant .
The multivariate analysis consisted of multiple linear regression . In each model, one and only one neurohormone was the dependent variable . The independent variables were the collection of demographic and clinical information as addressed for univariate analysis. These independent variables were analyzed all at once in the multiple regression model . A set of independent variables that had a significant relation with the individual neurohormones in the multivariate analysis was identified . Multicolinearity was assessed on the basis of measurements of variance inflation factor, tolerance, condition index and condition number and found not to present a problem in our multiple regression models . As in the univariate analysis, p values from the multiple regression analyses were based on the value of the coefficients from the regression equations and any p value < 0 .05 was considered statistically significant .
Results
Because the majority of neurohumoral samples were drawn 7 to 16 days after the myocardial infarction, the timing of neurohumoral sampling was found not to influence neurohumoral values in this study .
Plasma neurohormones . The increase in circulating neurohumoral levels was widespread, with SAVE patients havValues are mean value ± SD . The p values compare SAVE participants with age-matched normal subjects . N/A = left ventricular ejection fraction not obtained in normal subjects. Plasma Renin Activity (ng/ml/h) ing an increase in all measured neurohormoneE (plasma norepinephrine, 301 ± 193 vs. 222 ± 87 pg/ml ; plasma renin activity, 3 .0 ± 3.7 vs . 1 .2 t 1 .2 nglml per h ; arginine vasopressin, 1 .9 ± 6.9 vs . 0 .7 t 3 pg/ml, and atrial natriuretic peptide, 75 ± 75 vs . 21 ± 9 pg/mI [all p < 0 .001]) except plasma epinephrine, which was not increased (Table  I, Fig. 1 ) . Forty-eight percent of all patients had activation (>2 SD above the mean of age-matched control subjects) of at least one of the vasoconstrictor neurohormones (plasma renin activity, norepinephrine or arginine vasopressin) and 61% had activation of the vasodilator neurohormone atrial natriuretic peptide . However, despite this general increase in neurohumoral activation, a wide spectrum of neurohumoral values could be found at all levels of left ventricular ejection fraction, including many normal or low values whether or not diuretic drugs were being used ( Fig . 2 and 3) .
Plasma norepinephrine values were distributed in a bellshaped curve skewed to the right (Fig . IA) . A total of 22% of patients had values >2 SD above the mean value of control subjects (expected 2 .5%) . As plasma renin activities increased, the number of patients at each level of activation decreased (Fig . 1B) . Although many patients had normal levels, 22% had values >2 SD above the mean value in control subjects. This increase in plasma renin activity occurred whether or not patients were receiving diurtic drugs ( Table 1 ) . The pattern of increase in plasma aldosterone resembled that of plasma renin activity . A, Plasma norepinephrine. Twenty-two percent of patients had values >2 SD above the mean in normal control subjects ; 2% of patients had values greater than those shown . B, Plasma renin activity . Twenty-two percent of patients had values >2 SD above the mean in normal control subjects ; 2% of patients had values greater than those shown. The minimal measurable value varied between 0 .5 and 0 .6 ng/ml per h . C, Plasma arginine vasopressin . Twenty-seven percent of patients had values >2 SD above the mean in normal control subjects ; 2% of patients had values greater than those shown . The minimal measurable value was 0 .5 pg/ml . D, Plasma atrial natriuretic peptide . Sixty-one percent of patients had values >2 SD above the mean in normal control subjects ; 2% of patients had values greater than those shown . In A through D, each panel represents the mean value ± SD and the p value for age-matched control subjects and SAVE patients .
The wide range in values occurred with arginine vasopressin (Fig. IC) . Again, as arginine vasopressin values increased, the number of patients at each level of activation decreased . The majority of patients had arginine vasopressin values within the normal range ; nevertheless, 27% of patients had values >2 SD above the normal mean. This increase in arginine vasopressin in the SAV E patients is all the more impressive because it occurred despite a decrease in plasma osmolality and in patients not receiving diuretic drugs ( Table   1 ) . The increase in arginine vasopressin occurred in patients with an osmolality within I SD of that in normal control subjects (1 .45 ± 1 .65 pg/ml, p < 0.001) and in patients with an osmolality >1 SD above that in control subjects (29 ± 3 .74 p&/ml, p < 0.001). Patients with an osmolality <1 SD below that in control subjects also tended to have a higher arginine vasopressin value (2.05 ± 10.4 pg/mI, p = 0.06) .
The greatest increase in any neurohormone occurred with atria) natriuretic peptide (Fig. ID) . Values were distributed in a bell-shaped curve skewed largely to the right . A total of 61% of patients had an increase in atrial natriuretic peptide to levels >2 SD above the normal mean .
Neurohumoral activation occurred whether or not diuretic drugs were being used (Table 1 , Fig . 2 and 3) . Patients not receiving diuretic drugs (about two thirds of the group) had better left ventricular (p < 0 .001) and renal (p < 0 .001) function and were younger (p < 0 .001) . Nevertheless, they also had a significant increase in plasma renin activity, norepinephrine, arginine vasopressin and atrial natriuretic peptide compared with normal control subjects . Not surprisingly, a reasonably gd od correlation existed between levels of the various plasma catecholamines (Table 2) . A similarly significant corrmlation was found between plasma renin activity and aldosterone (Table 2 ) . Correlation, although weaker, were also found between plasma norepinephrine and plasma renin activity and aldosterone . Other correlations included atrial natriuretic peptide and norepinephrine and epinephrine, and arginine vasopressin and epinephrine and aldosterone . The use of diuretic drugs did not modify these correlations in a major way . Determinants of neurohnmoral activation (Table 3) . B_ univariate analysis, plasma norepinephrine values were related to age, Killip class, left ventricular ejection fraction and the use of diuretic drugs. The relation between Killip class, norepinephrine and other neurohormones is illustrated in Figure 4 , in which neurohumoral levels are plotted against Killip class . Multivariate analysis revealed only Killip class, ejection fraction and age as important, with the use of diuretic drugs no longer being related to circulating norepinephrine levels (Table 3) . By multivariate analysis, plasma epinephrine values were related to Killip class and ejection fraction and plasma dopamine values were related to Killip class, the use of thrombolytic therapy and diabetes (Table 3) .
By univariate analysis, plasma renin activity was related to the use of diuretic drugs, left v e n t r i c u l a r ejection fraction, Killip class and the use of digoxin . However, by multivariate analysis, only the use of diuretic drugs and ejection fraction were important, with Killip class being marginal and the use of digoxin insignificant (Table 3) . By multivariate analysis, plasma aldosterone was related to the use of diuretic drugs, systolic blood pressure at the time of sampling and Killip class (Table 3) . By univariate analysis, plasma arginine vasopressin levels were related to seven variables, but by multivariate analysis, only Killip class, age, diuretic drugs and diabetes were important (Table 3) .
Plasma atrial natriuretic peptide had the largest increase of al! neurohormones -a essured . By univariate analysis, atrial natriuretic peptide levels could be correlated with nine variables. However, by multivariate analysis, only left ventricular ejection fraction, the use of thiombolytic agents, prior myocardial infarction or blood pressure requiring therapy before the SAVE-myocardial infarction were found to be important (Table 3) . Tile relation between atrial natriuretic peptide and Killip class was marginal .
Discussion
We believe that our study is the first to indicate that widespread neurohumoral activation occurs at the fine of hospital discharge in patients with left ventricular dysfunction but without overt heart failure after myocardial infarction . In 48% of patients, significant activation (>2 SD above the mean of age-matched control subjects) of at least one vasoconstrictor neurohumoral system occurred . Also, 61% of patients had activation of the vasodilator neurohormone atrial natriuretic peptide . Activation of one neurohumoral system did not correlate with activation of another, indicating that factors regulating the activity of the various neurohumoral systems are at least partially independent of one another.
Neurohumoral activation in the SAVE patients was clearly greater than that in patients in the asymptomatic (prevention) arm of the Study of Left Ventricular Dysfunction (SOLVD) study (9) even though the two groups had a similar left ventricular ejection fraction . In the SAVE patients, plasma renin activity was increased whether or not diuretic drugs were used . whereas in the SOLVD prevention group, plasma renin activity was increased only in patients receiving diuretic drugs . Also, in SAVE, both plasma arginine vasopressin and atrial natriuretic peptide were increased to a greater extent than they were in patients in the SOLVD prevention arm . These results indicate that patterns of neurohumoral activation differ between patients with left ventricular dysfunction but without overt heart failure a mean of 12 days after infarction and patients with similar asymptomatic left ventricular dysfunction who have never had or have long since recovered from an acute myocardial infarction .
Compared with results in the SOLVD treatment or symptomatic group (9), the results of SAVE are variable, with arginine vasopressin being greater in SAVE patients, atrial natriuretic peptide bei.i,~, similar ant{ htet!~ "hcm~ renirt activity and plasma norepinephrine being somewhat !ewer than values in the SOLV ;u treatment group. The significance of neurohumoral activation before hospital discharge after infarction and in patients with chronic heart failure may also BP Req Rx = hypertension requiring therapy before the index myocardial infarcdon in the Survival and Venricular Enlargement (SAVE) study patients. Killip class is that obtain-A within 72 h after infarction (for details, see Methods) ; LVEF = left ventricular ejection fraction: Ml = myocardial infarction .
be different because the use of angiotensin-converting inhibitors in the SAVE patients improved survival equally well in patients with ?30% but <_40% and in patients with an ejection fraction <30%, whereas in SOLVD, the benefit in patients with an ejection fraction z30% was much less than that in patients with an ejection fraction <30% (3) (4) (5) .
Determinants of neurhwnoral activation . Seve1 al clinical variables and one laboratory test were identified as independent predictors of neurohumoral activation, the importance of each varying from one neurohortnone to another . Time of sampling did not significantly influence levels of any of the neurohormones measured. Because neurohumoral levels vary widely during the first few days after infarction (I), at first glance this observation may appear surprising . However, all previous studies have also indicated that the hyperacute rise after infarction subsides by 7 days to attain more stable levels and because the overwhelitting majority of samples in this study were drawn between 8 and 16 days, a time when the hyperacute increase in neurohormones is • a- past, the lack of time dependence in our study is understandable .
Not surprisingly, left ventricular ejection fraction, a reflection of left ventricular systolic function, appeared to influence the activation of most neurohormones . Nevertheless, a large proportion of patients with the lowest quartile of election fraction had little or no neurohumoral activation ( Fig. 2 and 3 ), indicating that neurohumoral activation is the result not simply of left ventricular dysfunction but of the convergence of numerous factors .
Ki:lip class a :@ assessed within 72 h of the myocardial infarction was the clinical variable most consistently associated with neurohumoral activation . Killip class is the result not only of systolic dysfunction but also of diastolic dysfunction and of sodium and water retention . That it was the only variable related to activation of all measured neurohormones and that this relation was independent of left ventricular ejection fraction underscore the importance of diastolic dysfunction in determining postinfarction neurohumoral activation . Alternatively, Killip class may simply identify patients with the greatest initial neurohumoral activation and thus at greatest risk of sustained neurohumoral activation. The use of diuretic drugs was found to be related to activation of the renin-angiotensin system and plasma arginine vasopressin . Other investigators (1) have described a strong relation between the use of diuretic drugs and activation of the renin-angiotensin system in this type of patient . However, we believe that this is the first time that persistent activation of the renin-angiotensin system has been shown to occur without the use of these agents . Early after infarction, patients are known to retain fluid (10) and to be predisposed to development of hyponatremia . In this study, SAVE patients had hypo-osmolality and thus had an inappropriate increase in circulating arginine vasopressin levels . It is therefore tempting to speculate that the relation between this neurohormone and the use of diuretic drugs is the result of arginine vasopressin-induced fluid retention and overload.
Age was found to be correlated with plasma norepinephrine and arginine vasopressin . The increase in plasma norepinephrine with age has been shown to be largely the result of an increase in spillover rate rather than of any alteration in extraction (11) . This increase in plasma norepinephrine with age combined with other poor prognostic signs such as decreased compliance, contractility and glomerular filtration rate known to occur with advancing age may help explain why older patients have a worse prognosis after infarction (12) . An increase in plasma arginine vasopressin with advancing age has already been described in normal patients (13) and thus tais relation was not surprising . The mechanism for this increase is poorly understood . No relation was found to occur between age and plasma renin activity or atrial natriuretic peptide . Under normal circumstances such a relation exists (14, 15) . Why it was not found in this situation remains speculative . Perhaps these relations were masked or overshadowed by other factors.
Other variables independently related to neurohumoral activation were the use of thrombolytic agents, prior myocardial infarction and hypertension requiring therapy before the SAVE myocardial infarction for atrial natriuretic peptide, and diabetes for arginine vasopressin . The inverse relation between the use of thrombolytic agents and atrial natriuretic peptide after infarction has previously been documented and is thought to be at least partially the result of prevention of ventricular dilation by the use of thrombolytic therapy. The correlation between atrial natriuretic peptide and prior myocardial infarction and hypertension requiring therapy before the SAVE myocardial infarction probably reflects the myocardial compliance problems related to these disease processes . An exaggerated increase in arginine vasopressin in response to stress in diabetes, although still controversial, has previously been described (16) .
Certain variables previously shown to affect neurohumoral activation were not found to be important in this study . Medications such as beta-blockers (17, 18) , calcium channel blockers (19, 20) , nitrates (21) and digoxin (22, 23) , ROULEAU ET AL.
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which have been fund L modify neurohumoral levels under certain circumstances, were found to be unrelated to neurohumoral activation . This lack of efft ct may have occurred because measurements were oLtained after these drugs were withheld for 712 h or because their effects were overwhelmed by other more important factors .
Conclusions. This study indicates that widespread neurohumoral activation occurs at the time of hospital discharge in many patients with left ventricular dysfunction but no overt heart failure after infarction . This pattern differs from that of patients with chronic left ventricular dysfunction but without overt heart failure (SOLVD prevention arm) in whom less activation of the plasma renin activity, arginine vasopressin and atrial natriuretic peptide systems occurs (9) , indicating that a unique profile of neurohumoral activation occurs at a mean of 12 days after infarction in patients with left ventricular dysfunction but no overt heart failure . This activation vanes widely from patient to patient and is not wholly the result of left ventricular d, sfunction or of the use of diuretic drugs . A significant number of patients who have a very low ejection fraction and are taking diuretic drugs have no neurohumoral activation, whereas an equally important group of patients who have a higher ejection fraction and are not taking diuretic drugs have marked activation . Killip class, left ventricular ejection fraction, the use of diuretic drugs and age are the clinical and laboratory variables most closely related to neurohumoral activation .
